Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Novel Approaches Towards a Functional Cure of HIV/AIDS.
Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study.
SARS-CoV-2 Consensus-Sequence and Matching Overlapping Peptides Design for COVID19 Immune Studies and Vaccine Development.
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02).
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.
Attachment Styles, Condomless Sex, and Drugs in HIV-Positive Gay and Bisexual Men.
TOX is expressed by exhausted and polyfunctional human effector memory CD8 + T cells
Correction to: Novel Approaches Towards a Functional Cure of HIV/AIDS.
Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agent.